HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Von Eschen, K. B. Articles by Rudbach, J. A. Search for Related Content PubMed Articles by Von Eschen, K. B. Articles by Rudbach, J. A.

Antibody Responses of Mice to Alkaline Detoxified Lipopolysaccharide¹

From the Department of Microbiology, University of Montana, Missoula, Montana 59801

Abstract

The antibody responses of outbred normal mice and nude mice injected with alkaline detoxified lipopolysaccharide (Alk-LPS) were measured. In some cases the antibody responses to Alk-LPS were compared to responses made against lipopolysaccharide (LPS) and native protoplasmic polysaccharide (NPP). The kinetics of the primary responses to Alk-LPS and NPP were similar, whereas LPS stimulated a more rapid appearance of antibodies in the primary responses. Alk-LPS stimulated only primary antibody responses in both types of mice and sensitized nude mice for secondary responses which could be triggered with LPS. However, secondary antibody responses could not be triggered in normal mice primed with Alk-LPS. These data suggested that, on a functional basis, Alk-LPS possessed the specific antigenic signal associated with LPS antigens but lacked the second nonspecific mitogenic signal dependent on the lipid A portion of LPS.

Footnotes

¹ This work was supported, in part, by Public Health Service Training Grant 5-T01-A100385.

² Present address: National Jewish Hospital and Research Center, 3800 East Colfax Avenue, Denver, Colorado 80206.

This article has been cited by other articles:

				A. Visintin, K. A. Halmen, E. Latz, B. G. Monks, and D. T. Golenbock Pharmacological Inhibition of Endotoxin Responses Is Achieved by Targeting the TLR4 Coreceptor, MD-2 J. Immunol., November 15, 2005; 175(10): 6465 - 6472. [Abstract] [Full Text] [PDF]